PAS219

DB03114ExperimentalSmall molecule

PAS219: Overview.

Mechanism: Pharmacologically active on Proto-oncogene tyrosine-protein kinase Src
Curator reviewed
Formula / weight: C₁₄H₁₉O₅P · 298.2714 g/mol (avg)
Code names: PAS219

Resolves to

Compound

Structure

InChIKeyYBEVTZVQKMYQPM-UHFFFAOYSA-NSMILESO[P@@](=O)(OCC1CCCCC1)OC1=C(C=O)C=CC=C1

Targets

What you can answer from here — as of August 31, 2026

1Protein targetEach mapped to UniProt, with action and pharmacological action

Listed above

2+ReferencesStructured and connected to the statements they support

Which drugs share a target with PAS219, and which of those have an active Phase 3 trial?

Create a free account or log in to explore the full data card.